Gregory T Everson

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Pulmonary Artery

Tyrosine Kinase

Top Venues

Alimentary pharmacology & therapeutics

Basic & clinical pharmacology & toxicology

Clinical and translational science

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Tarek Hassanein, Andrew P Keaveny, Parvez Mantry, Alastair D Smith, Michael P McRae, John Kittelson, Steve Helmke, Gregory T Everson, null null
Liver function and portal-systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices. Alimentary pharmacology & therapeutics (2024)
Michael P McRae, John Kittelson, Steve M Helmke, Gregory T Everson
Advances in noninvasive measurement of liver function and physiology: The HepQuant DuO test. Basic & clinical pharmacology & toxicology 134 (3) (2024)
Eric J Lawitz, Judith Ertle, Corinna Schoelch, Isabella Gashaw, Michael P McRae, Steve M Helmke, Gregory T Everson
Hepatic improvement within 27 days of avenciguat treatment in Child-Pugh A cirrhosis detected by an oral cholate challenge test. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2024)
Michael P McRae, John Kittelson, Steve M Helmke, Gregory T Everson
Advances in noninvasive measurement of liver function and physiology: The HepQuant DuO test. Basic & clinical pharmacology & toxicology 134 (3) (2024)
Michael P McRae, John Kittelson, Steve M Helmke, Gregory T Everson
Advances in noninvasive measurement of liver function and physiology: The HepQuant DuO test. Basic & clinical pharmacology & toxicology (2024)
Tarek Hassanein, Andrew P Keaveny, Parvez Mantry, Alastair D Smith, Michael P McRae, John Kittelson, Steve Helmke, Gregory T Everson, null null
Liver function and portal-systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices. Alimentary pharmacology & therapeutics 60 (2) (2024)
Michael P McRae, John M Kittelson, Steve M Helmke, Gregory T Everson
Within-individual reproducibility of a dual sample oral cholate challenge test (DuO) and simplified versions of the HepQuant SHUNT test. Clinical and translational science 17 (4) (2024)
Tarek Hassanein, Andrew P Keaveny, Parvez Mantry, Alastair D Smith, Michael P McRae, John Kittelson, Steve Helmke, Gregory T Everson, null null
Editorial: Reading the cholate-A new gateway to portal hypertension and oesophageal varices: Authors' reply. Alimentary pharmacology & therapeutics (2024)
Tarek Hassanein, Andrew P Keaveny, Parvez Mantry, Alastair D Smith, Michael P McRae, John Kittelson, Steve Helmke, Gregory T Everson, null null
Editorial: Reading the cholate-A new gateway to portal hypertension and oesophageal varices: Authors' reply. Alimentary pharmacology & therapeutics 60 (3) (2024)
Michael P McRae, John M Kittelson, Steve M Helmke, Gregory T Everson
Within-individual reproducibility of a dual sample oral cholate challenge test (DuO) and simplified versions of the HepQuant SHUNT test. Clinical and translational science 17 (4) (2024)
Jitendra Kanodia, Hugh Giovinazzo, Wayne Yates, David L Bourdet, Michael P McRae, Steve M Helmke, Gregory T Everson
Hepatic Dysfunction Quantified by HepQuant DuO Outperforms Child-Pugh Classification in Predicting the Pharmacokinetics of Ampreloxetine. Clinical pharmacology and therapeutics 116 (1) (2024)
Michael P McRae, John Kittelson, Steve M Helmke, Gregory T Everson
Advances in noninvasive measurement of liver function and physiology: The HepQuant DuO test. Basic & clinical pharmacology & toxicology 134 (3) (2024)
Tarek Hassanein, Andrew P Keaveny, Parvez Mantry, Alastair D Smith, Michael P McRae, John Kittelson, Steve Helmke, Gregory T Everson, null null
Editorial: Reading the cholate-A new gateway to portal hypertension and oesophageal varices: Authors' reply. Alimentary pharmacology & therapeutics 60 (3) (2024)
Tarek Hassanein, Andrew P Keaveny, Parvez Mantry, Alastair D Smith, Michael P McRae, John Kittelson, Steve Helmke, Gregory T Everson, null null
Liver function and portal-systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices. Alimentary pharmacology & therapeutics 60 (2) (2024)
Tarek Hassanein, Andrew P Keaveny, Parvez Mantry, Alastair D Smith, Michael P McRae, John Kittelson, Steve Helmke, Gregory T Everson, null null
Liver function and portal-systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices. Alimentary pharmacology & therapeutics 60 (2) (2024)
Jitendra Kanodia, Hugh Giovinazzo, Wayne Yates, David L Bourdet, Michael P McRae, Steve M Helmke, Gregory T Everson
Hepatic Dysfunction Quantified by HepQuant DuO Outperforms Child-Pugh Classification in Predicting the Pharmacokinetics of Ampreloxetine. Clinical pharmacology and therapeutics (2024)
Mohammad Amin Fallahzadeh, Daniel J Hansen, James F Trotter, Gregory T Everson, Giovanna Saracino, Robert S Rahimi, Steve Helmke, Jodi Boutte, Sumeet K Asrani
Predicting clinical decompensation in patients with cirrhosis using the Hepquant-SHUNT test. Alimentary pharmacology & therapeutics 53 (8) (2021)
Sumeet K Asrani, Gregory T Everson
Editorial: stratifying risk of adverse outcomes in cirrhosis-the Hepquant SHUNT test. Authors' reply. Alimentary pharmacology & therapeutics 53 (8) (2021)